Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer.

H Richly; P Kupsch; K Passage; M Grubert; R A Hilger; R Voigtmann; B Schwartz; E Brendel; O Christensen; C G Haase

doi:10.5414/cpp42650

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer.

Identifier:nobleid.org/w1/20260515/AFE3CD3F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AFE3CD3F.svg?ark=w1%2F20260515%2FAFE3CD3F)](https://nobleid.org/work/w1/20260515/AFE3CD3F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer.

Identifier:nobleid.org/w1/20260515/AFE3CD3F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AFE3CD3F.svg?ark=w1%2F20260515%2FAFE3CD3F)](https://nobleid.org/work/w1/20260515/AFE3CD3F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work